Antibiotic composition
US4226879A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Sep 1, 1978 |
| Grant date | Oct 7, 1980 |
| Priority date | — |
| Expiry date | Sep 1, 1998 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23K20/195
- WIPO fieldFood chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a new composition designated as AM-1042 or asukamycin. AM-1042 has an antibiotic activity upon Gram-positive bacteria and Eimeria, and its acute toxicity (LD.sub.50 ' ip.) in mice was 48.5 mg./kg. AM-1042 has an excellent therapeutical effect on various infectious diseases caused by a parasite of Gram-positive bacteria and Eimeria. AM-1042 has been confirmed to be distinguishable from known antibiotics such as e.g. amicetin B, azomycin and manumycin. AM-1042 is produced by fermentation of a microorganism belonging to the genus Streptomyces and capable of producing AM-1042. A composition capable of preventing and curing coccidiosis of poultry containing AM-1042 as active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.